These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34305780)

  • 1. High Prevalence of Early Parkinson's Disease in Patients With Subtle Parkinsonian Signs.
    Sasaki S
    Front Neurol; 2021; 12():656679. PubMed ID: 34305780
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up study of SWEDD patients with mild parkinsonian signs.
    Sasaki S
    BMJ Neurol Open; 2024; 6(1):e000600. PubMed ID: 38665250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Parkinson's disease by neuromelanin-sensitive magnetic resonance imaging and
    Kuya K; Ogawa T; Shinohara Y; Ishibashi M; Fujii S; Mukuda N; Tanabe Y
    Acta Radiol; 2018 May; 59(5):593-598. PubMed ID: 28743197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating.
    Schüpbach WM; Corvol JC; Czernecki V; Djebara MB; Golmard JL; Agid Y; Hartmann A
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):20-5. PubMed ID: 19622523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonian axial signs in schizophrenia.
    Morgante F; Barbui C; Tinazzi M;
    Parkinsonism Relat Disord; 2017 Mar; 36():89-92. PubMed ID: 28038867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between striatal
    Sawada H; Orimo S
    Rinsho Shinkeigaku; 2019 Dec; 59(12):799-805. PubMed ID: 31761832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
    Jauković L; Ilić TV; Dopudja M; Ajdinović B
    Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Olfactory Impairment and Disease Severity and Duration in Parkinson's Disease.
    Sasaki S; Horie Y
    Mov Disord Clin Pract; 2020 Oct; 7(7):820-826. PubMed ID: 33043078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
    Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between [
    Ramani L; Malek N; Patterson J; Nissen T; Newman EJ
    Acta Neurol Scand; 2017 Apr; 135(4):400-406. PubMed ID: 27255673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between
    Terashi H; Taguchi T; Ueta Y; Mitoma H; Aizawa H
    J Neurol Sci; 2021 Jul; 426():117476. PubMed ID: 33975190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
    Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease.
    Benítez-Rivero S; Marín-Oyaga VA; García-Solís D; Huertas-Fernández I; García-Gómez FJ; Jesús S; Cáceres MT; Carrillo F; Ortiz AM; Carballo M; Mir P
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):122-9. PubMed ID: 22906618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of the Combined Use of
    Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
    Yonago Acta Med; 2018 Jun; 61(2):117-127. PubMed ID: 29946218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
    Benamer HT; Patterson J; Wyper DJ; Hadley DM; Macphee GJ; Grosset DG
    Mov Disord; 2000 Jul; 15(4):692-8. PubMed ID: 10928580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vision-based estimation of MDS-UPDRS scores for quantifying Parkinson's disease tremor severity.
    Liu W; Lin X; Chen X; Wang Q; Wang X; Yang B; Cai N; Chen R; Chen G; Lin Y
    Med Image Anal; 2023 Apr; 85():102754. PubMed ID: 36702036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.